A detailed history of Cypress Capital Management LLC (Wy) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cypress Capital Management LLC (Wy) holds 5 shares of GILD stock, worth $440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 5 -0.0%
Holding current value
$440
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $357 - $436
5 New
5 $0
Q2 2022

Aug 01, 2022

SELL
$57.72 - $65.01 $5,772 - $6,501
-100 Reduced 66.67%
50 $3,000
Q2 2021

Aug 10, 2021

SELL
$63.47 - $69.35 $268,858 - $293,766
-4,236 Reduced 96.58%
150 $10,000
Q1 2021

May 07, 2021

SELL
$60.0 - $68.46 $14,220 - $16,225
-237 Reduced 5.13%
4,386 $283,000
Q4 2020

Jan 29, 2021

SELL
$56.65 - $64.55 $195,669 - $222,955
-3,454 Reduced 42.76%
4,623 $269,000
Q3 2020

Oct 28, 2020

SELL
$62.1 - $78.08 $496 - $624
-8 Reduced 0.1%
8,077 $516,000
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $576,911 - $669,900
7,975 Added 7250.0%
8,085 $622,000
Q1 2020

May 06, 2020

BUY
$62.63 - $80.22 $6,889 - $8,824
110 New
110 $8,000
Q1 2019

May 06, 2019

SELL
$62.53 - $70.05 $21,885 - $24,517
-350 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$60.54 - $79.0 $49,945 - $65,175
-825 Reduced 70.21%
350 $22,000
Q3 2018

Oct 31, 2018

BUY
$71.28 - $78.92 $76,626 - $84,839
1,075 Added 1075.0%
1,175 $91,000
Q3 2017

Nov 07, 2017

BUY
$72.11 - $85.47 $7,211 - $8,547
100
100 $8,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cypress Capital Management LLC (Wy) Portfolio

Follow Cypress Capital Management LLC (Wy) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.